These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35130950)

  • 1. Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis.
    Liu T; Cai HC; Cai H; Chen M; Zhang W; Li J; Zhou DB; Cao XX
    Orphanet J Rare Dis; 2022 Feb; 17(1):39. PubMed ID: 35130950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
    Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
    Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
    Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
    Salama HA; Jazieh AR; Alhejazi AY; Absi A; Alshieban S; Alzahrani M; Alaskar A; Gmati G; Damlaj M; Abuelgasim KA; Alghamdi A; Alahmari B; Almugairi A; Alzahrani H; Bazarbachi A; Musa MOH; Goyal G
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e66-e75. PubMed ID: 32943371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
    Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histiocytosis and the nervous system: from diagnosis to targeted therapies.
    Cohen Aubart F; Idbaih A; Emile JF; Amoura Z; Abdel-Wahab O; Durham BH; Haroche J; Diamond EL
    Neuro Oncol; 2021 Sep; 23(9):1433-1446. PubMed ID: 33993305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT2 expression in histiocytoses.
    Ungureanu IA; Cohen-Aubart F; Héritier S; Fraitag S; Charlotte F; Lequain H; Hélias-Rodzewicz Z; Haroche J; Donadieu J; Emile JF
    Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.
    Banks SA; Bhatti MT; Go RS; Abeykoon JP; Acosta-Medina AA; Hazim AZ; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Sartori Valinotti JC; Bennani NN; Shah MV; Rech KL; Garrity JA; Tobin WO;
    Ophthalmology; 2023 Jan; 130(1):77-86. PubMed ID: 35932838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking.
    Gallego CT; Bueno J; Cruces E; Stelow EB; Mancheño N; Flors L
    Radiologia (Engl Ed); 2019; 61(3):215-224. PubMed ID: 30686482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological Manifestations of Histiocytic Disorders.
    Banks SA; Sartori Valinotti JC; Go RS; Abeykoon JP; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Bennani NN; Shah MV; Rech KL; Tobin WO;
    Curr Neurol Neurosci Rep; 2023 Jun; 23(6):277-286. PubMed ID: 37209319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis.
    Aaroe A; Kurzrock R; Goyal G; Goodman AM; Patel H; Ruan G; Ulaner G; Young J; Li Z; Dustin D; Go RS; Diamond EL; Janku F
    Blood Adv; 2023 Aug; 7(15):3984-3992. PubMed ID: 36857436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis.
    Chang L; Lang M; Lin H; Cai H; Duan MH; Zhou DB; Cao XX
    Leukemia; 2024 Apr; 38(4):803-809. PubMed ID: 38388646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary manifestations of Erdheim-Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis.
    Wang JN; Wang FD; Sun J; Liang ZY; Li J; Zhou DB; Tian X; Cao XX
    Br J Haematol; 2021 Sep; 194(6):1024-1033. PubMed ID: 34423426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review.
    Aouba A; Larousserie F; Le Guern V; Martin A; Guillevin L
    Joint Bone Spine; 2009 Dec; 76(6):701-4. PubMed ID: 19640768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histiocytosis.
    Rocamora-Blanch G; Climent F; Solanich X
    Med Clin (Barc); 2023 Aug; 161(4):166-175. PubMed ID: 37263840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Go RS; Jacobsen E; Baiocchi R; Buhtoiarov I; Butler EB; Campbell PK; Coulter DW; Diamond E; Flagg A; Goodman AM; Goyal G; Gratzinger D; Hendrie PC; Higman M; Hogarty MD; Janku F; Karmali R; Morgan D; Raldow AC; Stefanovic A; Tantravahi SK; Walkovich K; Zhang L; Bergman MA; Darlow SD
    J Natl Compr Canc Netw; 2021 Nov; 19(11):1277-1303. PubMed ID: 34781268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging features of CNS histiocytosis syndromes.
    Wang Y; Camelo-Piragua S; Abdullah A; Ibrahim M; Parmar HA
    Clin Imaging; 2020 Mar; 60(1):131-140. PubMed ID: 31874337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.